Sun Z, Zhao H, Ma L, Shi Y, Ji M, Sun X
J Nanobiotechnology. 2024; 22(1):61.
PMID: 38355548
PMC: 10865557.
DOI: 10.1186/s12951-024-02311-z.
Hamley I
ACS Appl Bio Mater. 2022; 5(3):905-944.
PMID: 35195008
PMC: 9384901.
DOI: 10.1021/acsabm.1c01238.
Silva M, Kato Y, Melo M, Phung I, Freeman B, Li Z
Sci Immunol. 2021; 6(66):eabf1152.
PMID: 34860581
PMC: 8763571.
DOI: 10.1126/sciimmunol.abf1152.
Cortes H, Gomez F, Marshall S
Antibiotics (Basel). 2021; 10(7).
PMID: 34356768
PMC: 8300623.
DOI: 10.3390/antibiotics10070847.
Tomita Y, Watanabe E, Shimizu M, Negishi Y, Kondo Y, Takahashi H
Cancer Immunol Immunother. 2019; 68(10):1605-1619.
PMID: 31531696
PMC: 6805962.
DOI: 10.1007/s00262-019-02396-8.
Novel application of trimethyl chitosan as an adjuvant in vaccine delivery.
Malik A, Gupta M, Gupta V, Gogoi H, Bhatnagar R
Int J Nanomedicine. 2018; 13:7959-7970.
PMID: 30538470
PMC: 6260144.
DOI: 10.2147/IJN.S165876.
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.
Madani N, Princiotto A, Mach L, Ding S, Prevost J, Richard J
Nat Commun. 2018; 9(1):2363.
PMID: 29915222
PMC: 6006336.
DOI: 10.1038/s41467-018-04758-9.
A vaccine targeting basic fibroblast growth factor elicits a protective immune response against murine melanoma.
Zhang X, Li N, Guo C, Li Y, Luo L, Liu Y
Cancer Biol Ther. 2018; 19(6):518-524.
PMID: 29405828
PMC: 5927703.
DOI: 10.1080/15384047.2018.1435223.
Suppression of murine tumour growth through CD8 cytotoxic T lymphocytes via activated DEC-205 dendritic cells by sequential administration of α-galactosylceramide in vivo.
Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H
Immunology. 2017; 151(3):324-339.
PMID: 28294313
PMC: 5461099.
DOI: 10.1111/imm.12733.
Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.
Martinez-Donato G, Piniella B, Aguilar D, Olivera S, Perez A, Castanedo Y
Clin Vaccine Immunol. 2016; 23(4):370-8.
PMID: 26888185
PMC: 4820515.
DOI: 10.1128/CVI.00687-15.
Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination.
Fernandez A, Oliver L, Alvarez R, Fernandez L, Lee K, Mesa C
Hum Vaccin Immunother. 2014; 10(11):3251-60.
PMID: 25483674
PMC: 4514045.
DOI: 10.4161/hv.29847.
Inactivation of tumor-specific CD8⁺ CTLs by tumor-infiltrating tolerogenic dendritic cells.
Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C
Immunol Cell Biol. 2013; 91(9):545-55.
PMID: 24018532
PMC: 3806489.
DOI: 10.1038/icb.2013.38.
Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.
Sivakumar S, Safhi M, Kannadasan M, Sukumaran N
Saudi Pharm J. 2013; 19(4):197-206.
PMID: 23960760
PMC: 3744968.
DOI: 10.1016/j.jsps.2011.06.003.
New age adjuvants and delivery systems for subunit vaccines.
Kurella S, Manocha M, Sabhnani L, Thomas B, Rao D
Indian J Clin Biochem. 2012; 15(Suppl 1):83-100.
PMID: 23105272
PMC: 3454077.
DOI: 10.1007/BF02867548.
Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.
Reimer J, Karlsson K, Lovgren-Bengtsson K, Magnusson S, Fuentes A, Stertman L
PLoS One. 2012; 7(7):e41451.
PMID: 22844480
PMC: 3402407.
DOI: 10.1371/journal.pone.0041451.
Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination.
Xu Y, Cui L, Tian C, Zhang G, Huo G, Tang L
Clin Vaccine Immunol. 2011; 18(11):1979-86.
PMID: 21940406
PMC: 3209017.
DOI: 10.1128/CVI.05204-11.
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.
Chow S, Casadevall A
Vaccine. 2011; 29(10):1891-8.
PMID: 21238568
PMC: 3043149.
DOI: 10.1016/j.vaccine.2010.12.134.
Induction of tumor-specific acquired immunity against already established tumors by selective stimulation of innate DEC-205(+) dendritic cells.
Moriya K, Wakabayashi A, Shimizu M, Tamura H, Dan K, Takahashi H
Cancer Immunol Immunother. 2010; 59(7):1083-95.
PMID: 20221597
PMC: 2860563.
DOI: 10.1007/s00262-010-0835-z.
Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo.
Banerjee K, Andjelic S, Klasse P, Kang Y, Sanders R, Michael E
Virology. 2009; 389(1-2):108-21.
PMID: 19410272
PMC: 2743082.
DOI: 10.1016/j.virol.2009.04.001.
Adjuvant effects of saponins on animal immune responses.
Rajput Z, Hu S, Xiao C, Arijo A
J Zhejiang Univ Sci B. 2007; 8(3):153-61.
PMID: 17323426
PMC: 1810383.
DOI: 10.1631/jzus.2007.B0153.